Search

everythinglearnresearchcommunity

for

Search:↓

The dense fine speckled pattern in ANA tests is common in autoimmune diseases, challenging previous beliefs that it was unrelated.

The antibody created from BCC tissues reacts similarly to both BCC and hair follicles, suggesting BCC may come from hair follicle cells.

Red fluorescence in AGA scalps is linked to different microbes.

Early stage bald spots are linked to skin inflammation and damage to the upper part of the hair follicle.

PD‐L1 and PD‐L2 may not effectively control immune activation in alopecia areata.

Alopecia areata is an autoimmune disease causing hair loss, and targeting macrophages may help treat it.

Some hair proteins are specific to hair, while others are also found in skin cells.

In alopecia areata, certain immune cells increase and express a protein linked to immune activation.

Certain proteins are essential for the growth of root hairs in barley.

A specific genetic mutation may increase male pattern baldness risk, especially in Europeans.

Expanded CD8+ T cells are linked to Alopecia Areata and may cause relapse after treatment.

Congenital atrichia with papular lesions is often misdiagnosed, and new diagnostic criteria can improve accuracy.

Immune activities and specific genes are important in male pattern baldness.

M-CSF-stimulated myeloid cells can cause alopecia areata in mice.

Down Syndrome patients with Alopecia Areata often have hypothyroidism and specific immune abnormalities.

Blocking interferon-gamma helps prevent and treat hair loss in Alopecia Areata.

BST2 is a key marker for hair loss disease alopecia areata.

Melanocytes might be targeted by the immune system in people with alopecia areata, but more research is needed.

Certain gene variations may increase the risk and severity of alopecia areata.

Certain genetic variants linked to immune response increase the risk of alopecia areata in Taiwanese people.

Hair loss gene linked to prostate issues.

Avian yolk antibodies offer a promising, ethical alternative for disease prevention and therapy.

Certain genes are linked to the risk of developing Alopecia Areata.

People with alopecia areata have higher levels of RBP4 protein and antibodies against it.

Injecting recipient splenocytes into donors' thymus can prevent graft-versus-host disease.

Alopecia areata is linked to immune system differences, with specific biomarkers like CXCL9 and CXCL10 being key for diagnosis and potential treatment targets.

CD4 T cells need IFN-γ to cause hair loss in alopecia areata.

RAGE is a potential target for melanoma treatment, but its effectiveness is uncertain due to variable expression levels.